Prior to performing NK cell cytotoxicity assays, we confirmed the expression of NKG2A and KIR2DL1 on the NK cells derived from COVID-19 positive patients utilized for these assays by flow cytometry (Supplemental Figure 1). This evidence concerns the gene KIR2DL1 and COVID-19.